Name of this trial: Katsis-1 What type of cancer is this for? Breast Cancer Who is this trial for? Subjects With Locally Advanced or Metastatic Breast Cancer What biomarkers are involved? ER+, HER2- What is the National Clinical Trial #? NCT07062965 https://clinicaltrials.gov/study/NCT07062965?term=NCT07062965&rank=1 Brief summary of this trial: Phase 3, open-label, randomized study of PF-07248144 +
